Practical management of riociguat in patients with pulmonary arterial hypertension
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Therapeutic Advances in Respiratory Disease, 13, 2019
- Schlagwort
-
-
- Ereignis
-
Veröffentlichung
- (wo)
-
Greifswald
- (wer)
-
Universität Greifswald
- (wann)
-
2019
- Urheber
- DOI
-
10.1177/1753466619868938
- URN
-
urn:nbn:de:gbv:9-opus-36361
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Halank, Michael
- Tausche, Kristin
- Grünig, Ekkehard
- Ewert, Ralf
- Preston, Ioana R.
- Universität Greifswald
Entstanden
- 2019
Ähnliche Objekte (12)
Tobacco Smoke Exposure in Pulmonary Arterial and Thromboembolic Pulmonary Hypertension
Pulmonary arterial hypertension related to congenital heart disease
Phosphodiesterase 10A upregulation contributes to pulmonary arterial hypertension
Aberrant epigenetic landscape in human pulmonary arterial hypertension
Role of dimethylarginine dimethylaminohydrolases (DDAH) in pulmonary arterial hypertension
The Protective Role of PPARgamma in Pulmonary Arterial Hypertension
Quality of life and biomarkers in pulmonary arterial hypertension
Arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Non-invasive risk prediction based on right ventricular function in patients with pulmonary arterial hypertension
Antifibrotic drugs: new candidates for the treatment of pulmonary arterial hypertension?
Risk stratification of pulmonary arterial hypertension using eight different cardiovascular biomarkers
Tobacco Smoke Exposure in Pulmonary Arterial and Thromboembolic Pulmonary Hypertension
Pulmonary arterial hypertension related to congenital heart disease
Phosphodiesterase 10A upregulation contributes to pulmonary arterial hypertension
Aberrant epigenetic landscape in human pulmonary arterial hypertension
Role of dimethylarginine dimethylaminohydrolases (DDAH) in pulmonary arterial hypertension
The Protective Role of PPARgamma in Pulmonary Arterial Hypertension
Quality of life and biomarkers in pulmonary arterial hypertension
Arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Non-invasive risk prediction based on right ventricular function in patients with pulmonary arterial hypertension
Antifibrotic drugs: new candidates for the treatment of pulmonary arterial hypertension?
Risk stratification of pulmonary arterial hypertension using eight different cardiovascular biomarkers
Tobacco Smoke Exposure in Pulmonary Arterial and Thromboembolic Pulmonary Hypertension
Pulmonary arterial hypertension related to congenital heart disease
Phosphodiesterase 10A upregulation contributes to pulmonary arterial hypertension
Aberrant epigenetic landscape in human pulmonary arterial hypertension
Role of dimethylarginine dimethylaminohydrolases (DDAH) in pulmonary arterial hypertension
The Protective Role of PPARgamma in Pulmonary Arterial Hypertension
Quality of life and biomarkers in pulmonary arterial hypertension
Arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Non-invasive risk prediction based on right ventricular function in patients with pulmonary arterial hypertension
Antifibrotic drugs: new candidates for the treatment of pulmonary arterial hypertension?